Muscle & Nerve · 2008 · 18 citations · 19 references
Life SciencesImmunologyOncologyAutoimmunityImmunopathologyImmunotherapyAutoimmune DiseasesImmunosuppressionImmunosuppressive TherapyMultiple MyelomaGlutamic Acid Decarboxylase AntibodiesImmune Reconstitution SyndromeInterferon-mediated PathologyTransplantation
Stiff-person syndrome (SPS) is an immunologically mediated central nervous system disorder that is infrequently associated with malignancy. We report a 31-year-old woman who developed SPS after autologous bone marrow transplantation and subsequent interferon treatment for multiple myeloma. Anti-glutamic acid decarboxylase (anti-GAD) antibody serology was positive. The myeloma remains in remission 10 years posttransplant. SPS has been described in association with lung cancer and breast cancer, thymoma, and Hodgkin lymphoma. This is the second report of SPS in a patient with myeloma and the first description of SPS following autologous transplantation. Aberrant immune reconstitution is known to occur following hematopoietic progenitor cell transplantation. Interferon is also known to augment the immune response posttransplant. We speculate that an aberrant posttransplant immune response may have caused both the SPS and an autologous graft-versus-myeloma effect, resulting in prolonged remission posttransplant.
19
Autoimmunity to Gephyrin in Stiff-Man Syndrome
Margaret H. Butler, Akito Hayashi, Norio Ohkoshi et al. · Neuron · 2000 · 215 citations · Full text